Drug Shortage Report for SURVANTA

Last updated on 2019-09-19 History
Report ID 93565
Drug Identification Number 02016109
Brand name SURVANTA
Common or Proper name SURVANTA 8mL vial
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) BERACTANT
Strength(s) 25MG
Dosage form(s) SUSPENSION
Route of administration INTRATRACHEAL
Packaging size 8mL vial (010401320)
ATC code R07AA
ATC description OTHER RESPIRATORY SYSTEM PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-10
Actual start date 2019-09-10
Estimated end date 2019-09-18
Actual end date 2019-09-18
Shortage status Resolved
Updated date 2019-09-19
Company comments We are currently on managing our inventory for Survanta 8 mL due to an unexpected increase in market demand. Shall you not be in the position to wait until the predicted resolution date for your order, we do have normal inventory levels of Survanta 4 mL that can be provided instead.
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-09-19 English Compare
v5 2019-09-18 French Compare
v4 2019-09-18 English Compare
v3 2019-09-11 French Compare
v2 2019-09-11 English Compare
v1 2019-09-11 English Compare

Showing 1 to 6 of 6